Faculty

Officer-in-Charge: Dr. Anuradha Choudhary, Associate Professor

 

 

CURRICULUM VITAE OF DR. ANURADHA CHOWDHARY

Dr. Anuradha Chowdhary, Associate Professor & Head, Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi is actively engaged in research and post-graduate teaching in Medical Mycology since 2001. She has over 70 publications in peer reviewed International and National journals and she has also attended many International Conferences to present her research work. She is a Fellow of Infectious Diseases Society of America. Currently working on molecular ecology of pathogenic fungi and epidemiology of systemic mycoses especially cryptococcosis, aspergillosis and histoplasmosis through various sponsored research projects. These projects are funded by ICMR, DST and DBT, Govt. of India. Her laboratory has generated comprehensive data on molecular types and antifungal susceptibility profiles of indigenous fungal isolates such as C. neoformans, C. gattii, Aspergillus spp., Schizophyllum commune and Mucorales.  She has reported for the first time multi-azole resistant clinical isolates of Aspergillus fumigatus in India, new colonal strains of multi-drug resistant Candida auris in India. Also, her team has highlighted the clinical significance of non-sporulating fungi especially basidiomycetes in patients of respiratory diseases.

 

EDUCATIONAL QUALIFICATIONS

1.       M.B.B.S., Lady Hardinge Medical College, Delhi (University of Delhi) (1991)

2.       M.D. (Microbiology), Lady Hardinge Medical College, Delhi (University of Delhi) (1996)

3.   Ph.D. (Medical Sciences), Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (2012)

 

TRAINING ABROAD

Centers for Disease Control, Atlanta, USA, Aug 2003-July 2004, BOYSCAST Fellowship, by Department of Science and Technology, Govt of India.

Department of Biology, McMaster University, Hamilton, Ontario, Canada, July-Sept., 2009, ICMR International Fellowship.

Medical Mycology Course, Centraalbureau voor Schimmelcultures, Fungal Biodiversity Centre, Institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), Netherlands, March 2011. 

Department of Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, March-May 2011 and April-May 2012.

European Congress of
Clinical Microbiology and Infectious Diseases, (ECCMID) Fellowship, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, April 2013.

 

ADVANCED RESEARCH TRAINING ACQUIRED

 

1.   Expression of heterologous genes in yeast and bacteria" conducted by International Centre for Genetic Engineering and Biotechnology, New Delhi, October 28- November 8, 2002.

2.    "Laboratory Mycology: Quality, Cost-effectiveness and Clinical Relevance" organized by National Laboratory Training Network Nashville & CDC, Atlanta, Georgia U.S.A., August 14-15, 2003.

3.  Molecular Biology Course” conducted by CDC, Atlanta, GA, U.S.A., September 8 - December 8, 2003.

4.      "Research Methods in Epidemiology" conducted by CDC, Atlanta, GA, U.S.A. April 26 - May 27, 2004.

5.     Molecular Medical Mycology” conducted by The University of Melbourne, Australia and Mahidol University, Thailand in collaboration with Howard Hughes Medical Institute, USA, November 22-29, 2009, Bangkok, Thailand.

6.    Medical Mycology Course conducted by the Centraalbureauvoor Schimmelcultures, Fungal Biodiversity Centre, Institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), The Netherlands, March 7-18, 2011. 

 

AWARDS AND RECOGNITION

 

International:

 

1. Awarded George McCracken Infectious Disease Fellowship grant by American Society of Microbiology to participate 44th Inter-Science Conference on Antimicrobial Agents & Chemotherapy Washington, DC, October 30-November 2, 2004.

2.  Expert, World Health Organization (WHO), for the Development of the Global Report on Antimicrobial Resistance (AMR). June 2013.

3. Member Expert, European Society of Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology (ECMM) Joint Guidelines on Diagnosis and Management of Emerging Fungal Diseases: ESCMID-ECMM guidelines, on Phaeohyphomycosis 2012-2013.

4. Member Expert, International Expert opinion meeting on the management of azole resistance in Aspergillus fumigatus Copenhegan, Denmark, Oct., 2013 by Dutch Society for Medical Mycology.

5. Recipient of ALFUN Fellowship to participate 6th Advances Against Aspergillosis, Madrid, Spain, February 27- March 1, 2014.

6. Fellow, Infectious Diseases Society of America, 2014

7. Director, Asia Pacific Society of Medical Mycology, July 2014.

 

National:

Awarded Research grant under Young Scientists SERC Fast track scheme of DST (Department of Science and Technology, Govt of India 2005-08). Project title: “Environmental prevalence of Cryptococcus neoformans, its mycoserologic and genotypic characterization and role in pulmonary infections”.

 

Best Paper Awards

1. “Chlamydia trachomatis in Pelvic Inflammatory Disease” by Indian Association of Medical Microbiologists (IAMM), Delhi Chapter Meeting, November 1997.

2.  Prevalence of Toxoplasma infection in mothers and neonates in a teaching Hospital, New Delhi" by IAMM, Delhi Chapter Meeting, March 26, 1998.

3. Malassezia furfur as an etiologic agent of onychomycosis: first case from India." by IAMM, Delhi Chapter Meeting, 7th September 2002.

4.  “Experience with cryptococcosis in HIV patients in a North Delhi Hospital” presented at 7th National Conference of Society for Indian Human and Animal Mycologists, (SIHAM 2008), Seth GS Medical College & KEM Hospital, Mumbai, February 4-6, 2008.

5. NAWOPIA-95 Dr Pankajalakshmi V. Venugopal Prize for a paper titled; “A study of species spectrum and antifungal susceptibility pattern of opportunistic pathogenic fungi isolated from HIV patients in New Delhi” presented at 32nd Annual Congress of Indian Association of Medical Microbiologists (IAMM), Armed Forces Medical College, Pune, October 21-25, 2008.

6.  Dr. Shriniwas best paper entitled, “Antifungal susceptibility profile and molecular typing of Cryptococcus neoformans and C. gattii isolates from India” presented at Annual Congress of Indian Association of Medical Microbiologists (IAMM), Delhi Chapter, Lady Hardinge Medical College, New Delhi, December 5, 2009.

7. “Evaluation of hypertonic Sabouraud’s glucose agar as a reliable medium for differentiation of Candida dubliniensis from Candida albicans” presented at VIII National Conference of Society for Indian Human and Animal Mycologists, (SIHAM 2010), AIIMS, New Delhi, March 4-6, 2010.

8. NAWOPIA Dr Pankajalakshmi V. Venugopal Prize for “Molecular characterization of germ tube positive Candida species with special reference Candida africana” presented at 36th Annual Congress of Indian Association of Medical Microbiologists (IAMM), Lady Hardinge Medical College, Delhi, November 2012.

9.  Dr. G.P. Agarwal Young Scientist Award for a joint paper entitled, “Isolation of multiple-triazole-resistant Aspergills fumigatus strains carrying TR34/L98H and TR46/Y121F/T289A mutations in cyp51A gene from clinical and environmental sources in India” presented at 10th National Conference of the Society for Indian Human and Animal Mycologists (SIHAM), Coimbatore, Tamil Nadu, January 10-12, 2014.

10.Best oral paper presentation entitled, “Microsatellite typing and antifungal susceptibility profiling of clinical and environmental Cryptococcus neoformans var grubii isolates from India” presented at 10th National Conference of the Society for Indian Human and Animal Mycologists (SIHAM), Coimbatore, Tamil Nadu, January 10-12, 2014.

11.Best poster presentation for a joint paper entitled, “. Blastobotrys serpentines: A cause of human disease” presented at 10th National Conference of the Society for Indian Human and Animal Mycologists (SIHAM), Coimbatore, Tamil Nadu, January 10-12, 2014.

 
EDITORIAL BOARD OF SCIENTIFIC JOURNALS

·   Academic Editor ‘PLoS One’

·   Deputy Editor - ‘Mycoses

·   Assistant Editor- ‘Indian Journal of Allergy, Asthma & Immunology’

·   Member, Editorial Board-  ‘Current Fungal Infection Reports

·   Member, Editorial Board- ‘Indian Journal of Chest Diseases and Allied Sciences

 

MEMBERSHIP OF SCIENTIFIC SOCIETIES

·   Infectious Diseases Society of America (IDSA).

·   International Society for Human and Animal Mycology (ISHAM).

·   American Society of Microbiology (ASM).

·   Society of Indian Human and Animal Mycologists (SIHAM).

·   Indian Association of Medical Microbiologists (IAMM), Delhi Chapter.

·   Hospital Infection Society of India.

 

MEMBERSHIP OF INTERNATIONAL EXPERT/ADVISORY COMMITTEE

 

·   Member, Panel of Experts, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and European Confederation of Medical Mycology (ECMM) Joint Guidelines on Diagnosis and Management of Emerging Fungal Diseases: ESCMID-ECMM guidelines, member expert on Phaeohyphomycosis 2012-2013.

 

·   World Health Organization (WHO) expert for Development of Global Report on Antimicrobial Resistance (AMR). June 2013.

 

·   Member expert on International expert opinion on the management of azole resistance in Aspergillus fumigatus, Dutch Society for Medical Mycology, October 2013.

 

·   Scientific Advisory Board, Faculty for 9th International Conference on Cryptococcus and Cryptococcosis, Amsterdam, the Netherlands, May 2014. 

 

INVITED FACULTY FOR INTERNATIONAL WORKSHOPS/COURSES

 

1. A workshop on “Zygomycete biodiversity”, Utrecht, The Netherlands, March 3-5, 2011.

 

2. Scientific workshop on “Global Health and Disease Treatment: Infectious Diseases”, Canada-India Research Centre of Excellence, University of Toronto, Canada, January 5-6, 2012,

 

3. ‘International workshop on Medical Mycology’ Nijmegen, Radboud University, the Netherlands, June 18-23, 2012.

 

4. European Society of Clinical Microbiology and European Confederation of Medical Mycology Joint Guidelines meeting on ‘Diagnosis and Management of Phaeohyphomycosis’. In-charge working group meeting, Cologne, Germany, October 8, 2012.

 

5. India/Canada–Centre for Innovative Multidisciplinary partnerships to Accelerate Community Transformation and Sustainability (IC-IMPACTS). “Canada-India Workshop on Building Healthy Communities”, February 21-22, 2013, Nagpur, India.

 

6. “The Future of Barcoding” A workshop by ISHAM working group Medical Barcoding, at CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands, April 12-13, 2013.

 

7. “Emerging Zygomycetes”, A workshop by ISHAM working group Medical Barcoding, at CBS-KNAW Fungal Biodiversity Centre, Utrecht, Netherlands. April 8-9, 2013.

 

8. International Expert Meeting on Management of Azole Resistance Aspergillosis’, Dutch Society of Medical Mycology, Copenhagen, Denmark, October 14-15, 2013.

 

9. Faculty, International Organizing Committee of the 9th International Conference on Cryptococcus and Cryptococcosis, Amsterdam, The Netherlands, 17-20 May 17-20, 2014.

 

10. Faculty at European Confederation of Medical Mycology (ECMM) Educational Course on “Emerging yeast infections”, Amsterdam, The Netherlands, May 15, 2014.

 

11. Faculty at 3rd International Forum on Zygomycosis, Athens, Greece, September 19-21, 2014.

 

NATIONAL COURSE/WORKSHOP ORGANISED/COURSE FACULTY

 

1. Pre-Conference CME on Nosocomial Fungal Infections of IX National Conference of Hospital Infection Society of India, Government Medical College Hospital, Chandigarh, February 16-18, 2007. (CME Faculty).

 

2. 6th Annual Conference of Delhi & NCR Chapter of Indian Society of Critical Care Medicine, Indraprastha Apollo Hospitals, New Delhi, September 27-30, 2007. (Pre-Conference CME Faculty).

 

3.  2nd CME Pediatric Infectious Diseases, Chacha Nehru Bal Chikitsalya, Delhi, January 17-18, 2009. (Course Faculty).

 

4.  9th CME, Seminar on Pneumonia, V. P. Chest Institute, Delhi, February 13, 2010. (Course Faculty).

 

5.  Indian Association of Medical Microbiologists 36th Annual Congress of IAMM, Delhi, November 22-25, 2012. Pre Conference Workshop on “Molecular Diagnostic Methods in Respiratory Infections”, Department of Microbiology, V.P. Chest Institute, November 21, 2012. (Organized the Mycology Training).

 

6. “Diagnostic Microbiology: Newer Trends and Advances, December 21, 2013, HIMSR & HAH Centenary Hospital, Jamia Hamdard, India. (Course Faculty).

 

7.  2nd MICROCON CME & WORKSHOP, Allahabad, March 30, 2014. (Course Faculty).

 

TEACHING EXPERIENCE/EXAMINER

 

·   Supervisor/Co-Supervisor of 14 M.D./Ph.D students including 10 M.D (Microbiology, Pulmonary Medicine, Medicine and ENT) and 4 ongoing Ph.D students Faculty of Medical Sciences, University of Delhi.

 

·   External Examiner Ph.D thesis, Microbiology, Faculty of Science, StellenBosch University, South Africa. 2013.

 

TRAINING TO INTERNATIONAL RESEARCH SCHOLARS

 

·   Ph.D student Dr. K.L. Becker, Department of Internal Medicine, Nijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands to work on “Immunogenic response of Aspergillus species in allergic bronchopulmonary aspergillosis patients” Dept. of Medical Mycology, VPCI, on August 5-17, 2013.  

 

·   WHO Fellow, Mr Wijedasa ( Course Title: Phenotypic of molecular characterization of pathogenic fungi and their antifungal susceptibility patterns) Lecturer, Department of Microbiology, University of Peradenyia, Sri Lanka, Dept. of Medical Mycology, VPCI, on February 27- April 25, 2014.

 

PUBLICATIONS : Over 70 publications in International and National journals.

 

International:

 

1.     Becker, Chowdhary A, Brück M, Kruse E, Schmalreck AF, Gugnani HC and Fegler W. Typing of Candida tropicalis strains: Genotyping using arbitrarily primed polymerase chain reaction versus phenotyping by Fourier transform-infrared primed spectroscopy. Mycoses 2002; 45: 7. Impact factor: 2.25.

 

2.   Chowdhary A, Becker K, Fegler W, Gugnani HC, Kapoor L, Randhawa VS, Mehta G. An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses 2003; 46: 269-274. Impact factor: 2.25.

 

3.   Chowdhary A, Bansal R, Singh K, Singh V. Ocular cysticercosis -a profile. Tropical Doctor 2003; 33: 185-188. Impact factor: 0.66.

 

4.   Singh V, Chowdhary A, Randhawa HS, Sharma S, Chandra J. Invasive pulmonary aspergillosis in a neonate treated successfully with amphotericin B and itraconazole - a case report. J. Mycol. Méd (Paris). 2004; 14: 129-133. Impact factor: 0.73.

 

5.     Chowdhary A and Singh K. Spectrum of fungal keratitis in North India. Cornea 2005; 24: 8-15. Impact factor: 1.73.

 

6.     Chowdhary A, Randhawa HS, Sharma S, Brandt ME, & Kumar S. Malassezia furfur in a case of onychomycosis: Colonizer or etiologic agent? Med. Mycol. 2005; 43: 87-90. Impact factor: 2.13.

 

7.   Chowdhary A, Lee-Yang W, Lasker BA, Brandt ME, Warnock DW, Arthington-Skaggs B. A “Comparison of multilocus sequence typing (MLST) and Ca3 fingerprinting for molecular subtyping of epidemiologically-related clinical isolates of Candida albicans” Med. Mycol. 2006; 44: 405-418. Impact factor: 2.13.

 

8.   Randhawa HS, Chowdhary A, Kowshik T, Sinha KP, Vijayan VK. Evaluation of peptone glucose fluconazole agar as a selective medium for rapid and enhanced isolation of Aspergillus fumigatus from respiratory tract of bronchopulmonary aspergillosis patients colonized by Candida albicans. Med. Mycol. 2006; 44: 343-348. Impact factor: 2.13.

 

9.   Randhawa HS, Kowshik T, Sinha KP, Chowdhary A, Khan ZU, Zhun Y, Xu J and Kumar A. Distribution of Cryptococcus gattii and Cryptococcus neoformans in decayed trunk wood of Syzygium cumini trees in north-western India. Med. Mycol. 2006; 44: 623-630. Impact factor: 2.13.

 

10.  Randhawa HS, Chowdhary A, Khanna G. Comments on Singh et al.’s ‘Cryptococcosis in a bandicoot rat’. Med. Mycol. 2007; 45: 655-656. Impact factor: 2.13.

 

11.  Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. Zygomycosis-A case report and overview of disease in India. Mycoses 2007; 50: 247-254. Impact factor: 2.25.

 

12.   Khan ZU, Randhawa HS, Kowshik T, Chowdhary A, Chandy R. Antifungal Susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in North-western India J Antimicrob Chemother 2007; 60: 312-316.  Impact factor: 5.07.

 

13.  Hiremath SS, Chowdhary A, Randhawa HS, Kowshik T, Sun S, Xu J.  Long distance dispersal and recombination in environmental populations of Cryptococcus neoformans var. grubii from India.  Microbiology 2008; 154: 1513-1524. Impact factor: 3.06.

 

14.  Randhawa HS, Kowshik T, Chowdhary A, Sinha KP, Khan ZU, Sun S, Xu J. The expanding host tree species spectrum of Cryptococcus gattii and Cryptococcus neoformans and their isolations from surrounding soil in India. Med. Mycol. 2008; 46: 823-833.  Impact factor: 2.13.

 

15.  Chowdhary A, Guarro J, Randhawa HS,  Gené J, Cano J,  Jain RK, Kumar S, Khanna G. A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med. Mycol. 2008; 46: 163-166. Impact factor: 2.13.

 

 

16. Khan ZU, Randhawa HS, Chehadeh W, Chowdhary A, Kowshik T, Chandy R. Cryptococcus neoformans, serotype A and Cryptococcus gattii, serotype B isolates differ in their susceptibilities to fluconazole and voriconazole. Int. J Antimicrob. Agents 2009; 33: 559-563. Impact factor: 3.03.

 

 

17.  Chowdhary A, Randhawa HS,  Khan ZU, Ahmad S, Khanna G, Gupta R, Chakravarty A, Roy P.  Rhinoentomophthoromycosis due to Conidiobolus coronatus - A case report and an overview of the disease in India.  Med. Mycol. 2010; 48: 870-879. Impact factor: 2.13.

 

 

18. Chowdhary A, Randhawa HS, Khan ZU, Ahmad S, Juneja S, Sharma B, Roy P, Sundar G, Joseph L. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen.  Med. Mycol. 2010; 48: 416-420. Impact factor: 2.13.

 

 

19. Chowdhary A, Hiremath SS, Sun S, Kowshik T, Randhawa HS,  Xu J. Genetic differentiation and clonal expansion of environmental populations of Cryptococcus gattii in India. Environ. Microbiol. 2011; 13: 1875-1888. Impact factor: 5.84.

 

 

20.  Chowdhary A, Randhawa HS, Kowshik T, Kathuria S, Roy P, Brandt ME. Application of hypertonic Sabouraud glucose agar for differentiation of Candida dubliniensis from Candida albicans. Diagn. Microbiol. & Infect. Dis. 2011; 4: 440-442. Impact factor: 2.45.

 

21.  Chowdhary A, Randhawa HS, Sundar G, Kathuria S, Prakash A, Khan ZU, Sun S, Xu J. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India. J Med. Microbiol. 2011; 60: 961-967. Impact factor: 2.5.

 

22.  Chowdhary A, Randhawa HS, Singh V, Khan ZU, Ahmad S, Kathuria S, Roy P, Khanna G, Chandra J. Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient. Med. Mycol. 2011; 49: 760-765. Impact factor: 2.13.

23.  Randhawa HS, Kowshik T, Chowdhary A, Prakash A, Khan ZU, Xu J. Seasonal variations in prevalence of Cryptococcus neoformans var grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north- western India: A retrospective study. Med. Mycol. 2011; 49: 320-323. Impact factor: 2.13.

 

24.  Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 2012; 67: 362-366. Impact factor: 4.16.

 

25. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF. Temperate climate niche for Cryptococcus gattii in Northern Europe.  Emerg. Infect. Dis. 2012; 18:172-174. Impact factor: 6.79.

 

26. Chowdhary A, Randhawa HS, Meis JF. Environmental Prevalence of Cryptococcus neoformans and C. gattii in India: An Update. Critical Rev. Microbiol. 2012; 38: 1–16. Impact factor: 6.27.

 

27.  Chowdhary A,  Agarwal, K,  Kathuria S, Kumar P, Roy P,  Gaur SN, Rodrigues AM, deHoog GS,  Meis JF. First human case of pulmonary fungal ball due to a Perenniporia-like species (Basidiomycetes). J Clin Microbiol 2012; 50: 3786-3791. Impact factor: 4.16.

 

28.  Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, Singh PK, Gaur SN, Hagen F,  Klaassen CH, Meis JF. Clonal Expansion and Emergence of Environmental Multiple-triazole-resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India. Plos ONE. 2012; 7:e52871. doi: 10.1371/journal.pone.0052871. Impact factor: 4.09.

 

29.  Chowdhary A,  Agarwal K, Randhawa HS, Kathuria S, Gaur SN,  Najafzadeh MJ, Roy P,  Arora N, Khanna G,  Meis JF. A rare case of allergic bronchopulmonary mycosis caused by Alternaria alternata. Med Mycol 2012; 50: 890-896. Impact factor: 2.13.

 

30.  Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, Fothergill A, Fuller J, Hagen F, Govender N, Guarro J, Johnson E, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, Trilles L, Kidd S, Turnidge J.  Cryptococcus neoformans-Cryptococcus gattii species complex: An International study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother.  2012; 56: 3107-3113. Impact factor: 4.84.

 

31.  Pan W, Khayhan K, Hagen F, Wahyuningsih R, Chakrabarti A, Chowdhary A, Ikeda R, Taj-Aldeen SJ, Khan Z, Imran D, Sjam R, Sriburee P, Liao W, Chaicumpar K, Ingviya N, Mouton JW, Curfs-Breuker I, Boekhout T, Meis JF, Klaassen CH. 2012. Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes. PLoS One. 2012; 7: e32868. doi: 10.1371/journal.pone.0032868. Impact factor: 4.09.

 

32. Espinel-Ingroff A, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S,  Cuenca-Estrella M, Fothergill A,  Fuller J,  Govender JN, Hagen F, Illnait-Zaragozi M1, Johnson E, Kidd S, Lass-Flörl C, Lockhart S, Martins MA,   Mazuelos E,  Meis JF,  M. S.C. Melhem, Ostrosky-Zeichner, T. Pelaez, M.A. Pfaller  W. A. Schell, G. St-Germain, L. Trilles, and J. Turnidge Cryptococcus neoformans-Cryptococcus gattii Species Complex: An International Study of wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole and Voriconazole. Antimicrob Agents Chemother. 2012; 56: 5898-906. Impact factor: 4.84.

 

33.  Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, Jain S, Kathuria S, Randhawa HS, Hagen F, Meis JF. New clonal strain of Candida auris, Delhi, India. Emerg. Infect. Dis. 2013; 10:1670-1673. Impact factor: 6.79.

 

34.  Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013; 9: e1003633. doi: 10.1371/journal.ppat.1003633. Impact factor: 9.07.

 

35.  Singh PK, Kathuria S, Agarwal K, Gaur SN, Meis JF, Chowdhary A. Clinical significance and molecular characterization of non-sporulating moulds isolated from the respiratory tract of bronchopulmonary mycoses patients with special reference to basidiomycetes. J Clin Microbiol 2013; 51: 3331-3337. Impact factor: 4.16

 

 

36. Khayhan K, Hagen F, Pan W, Simwami S, Fisher MC, Wahyuningsih R, Chakrabarti A, Chowdhary A, Ikeda R, Taj-Aldeen SJ, Khan Z, Ip M, Imran D, Sjam R, Sriburee P, Liao W, Chaicumpar K, Vuddhakul V, Meyer W, Trilles L, van Iersel LJ, Meis JF, Klaassen CH, Boekhout T. Geographically structured populations of Cryptococcus neoformans variety grubii in Asia correlate with HIV status and show a clonal population structure. PLoS One. 2013 Sep 3;8:e72222. doi: 10.1371/journal.pone.0072222. eCollection 2013. Impact factor: 4.09.

 

37.  Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Pelaez T, Pfaller MA, Turnidge J. Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 document): A Multicenter Study. Antimicrob Agents Chemother. 2013; 57: 3823-3828. Impact factor: 4.84.

 

38.  Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, Ansari S, Hagen F, Meis JF, Chowdhary A. Environmental study of azole-resistant Aspergillus fumigatus with TR34 /L98H mutations in the cyp51A gene in Iran. Mycoses. 2013; 56: 659-663. Impact factor: 4.84.

 

39.  Sharma C, Wankhede S, Muralidhar S, Prakash A, Singh PK, Kathuria S, Kumar DA, Khan N, Randhawa HS, Meis JF, Chowdhary A. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi. Diagn Microbiol Infect Dis. 2013; 76: 46-50. Impact factor: 2.45.

 

40.  Chowdhary A, Kathuria S, Singh PK, Agarwal K, Gaur SN, Roy P, Randhawa HS, Meis JF. Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune: an emerging basidiomycetes in bronchopulmonary mycoses. Antimicrob Agents Chemother. 2013; 57: 2845-2848. Impact factor: 4.84.

 

41.  Chowdhary A, Kathuria S, Agarwal K, Meis JF. Reply to “Implications of high antifungal susceptibility on Schizophylum commune-associated allergy in clinical practice.  Antimicrob Agents Chemother 2013; 57: 5784-5785. Impact factor: 4.84

 

42.  Chowdhary A, Prakash A, Randhawa HS, Kathuria S, Hagen F, Meis JF. First environmental isolation of Cryptococcus gattii, genotype AFLP5 from India and a global review. Mycoses 2013. 56: 222-228. Impact factor: 2.25

 

43.  Randhawa HS, Chowdhary A, Kathuria S, Roy P, Misra DS, Jain S, Chugh TD.  Blastomycosis in India: report of an imported case and current status. Med Mycol 2013; 51:185-92. Impact factor: 2.13.

 

44.  Chowdhary A, Agarwal K, Kathuria S, Singh PK, Roy P, Gaur SN, de Hoog GS, and Meis JF. Clinical significance of filamentous basidiomycetes, illustrated by the novel opportunist Ceriporia lacerata isolated from the human respiratory tract. J Clin Microbiol.  2013; 51: 585-590. Impact factor: 4.16.

 

45.  Chowdhary A, Randhawa HS, Kathuria S, Gaur SN, Roy P, Klaassen CH Meis JF. Schizophyllum commune as an emerging fungal pathogen: A review and report of two cases. Mycoses 2013; 56: 1-10. Impact factor: 2.25.

 

46. Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS and Meis JF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: A global overview. Crit Rev Microbiol. 2014; 40: 30-48. Impact factor: 6.27.

 

47.  Agarwal K, Kathuria S, Sundar G, Singh P, Khanna G, Chowdhary A. A case of allergic fungal rhinosinusitis due to Ceratocystis adiposa. Diagn Microbiol Infect Dis 2014; 78: 196-198. Impact factor: 2.45.

 

48.  Prakash A, Wankhede S, Singh PK, Agarwal K, Kathuria S, Sengupta S, Barman P, Meis JF, Chowdhary A. First neonatal case of fungemia due to Pseudozyma aphidis and a global literature review. Mycoses. 2014; 57: 64-68. Impact factor: 2.45.

 

49.  Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, Dinesh KR, Karim S, Singh SK, Hagen F, Meis JF. Multidrug resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol & Infect 2014; 33: 919-926. Impact factor: 3.024.

 

50. Chowdhary A, Sharma C, Kathuria S, Hagen F, Meis JF. Azole Resistant Aspergillus fumigatus with the Environmental TR46/Y121F/T289A Mutation in India. J Antimicrob Chemother; 2014; 69: 555-557. Impact factor: 4.16.

 

51.  Hagen F, Chowdhary A, Prakash A, Meis JF. Molecular characterization of Cryptococcus gattii genotype AFLP6/VGII isolated from woody debris of divi-divi (Caesalpinia coriaria), Bonaire, Dutch Caribbean. Rev Iberoam Micol. 2014;31:193-6. doi: 10.1016/j.riam.2013.10.007. Epub 2014 Feb 7 Impact factor: 1.312. 

 

52.  Chowdhary A, Meis JF, Guarro J, de Hoog SG, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabati A, Dannaoui E, Diepeningen A, Freiberger T, Groll AH, Hope WH, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson M.D, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M. ESCMID (European Society of Microbiology & Infectious Diseases)  & ECMM  (European Confederation of Medical Mycology) Guidelines on Diagnosis and Management of Systemic Phaeohyphomycosis: diseases caused by black fungi. Clin. Microbiol  Infect 2014;  3: 47-75. Impact factor: 4.578.

 

53.  Tortorano AM, Richardson MD, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, PE, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog GS, Hope WH, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Flörl C. ESCMID & ECMM Joint Guidelines on Diagnosis and Management of Hyalohyphomycosis:  Fusarium spp, Scedosporium spp, and others. Clin. Microbiol Infect 2014; 3: 27-46. Impact factor: 4.578.

 

54.  Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella MC, Tomas F, Guinea J, Guarro J, de Hoog GS, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Florl C, Lortholary O, Meis JF, Meletiadis J, Munoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G. ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013. Clin. Microbiol Infect 2014; 3: 5-26. Impact factor: 4.578.

 

55.  Chowdhary A, Sharma C, Hagen F, Meis JF. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanism. Future Microbiol. 2014; 9: 697-711. Impact factor: 4.08.  

 

56.  Sharma C, Muralidhar S, Xu J, Meis J. F., Chowdhary A. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India. Mycoses, 2014;57:544-52. doi: 10.1111/myc.12193. Epub 2014 Apr 3. Impact factor: 1.2.

 

57.  Kathuria S, Singh PK, Meis JF, Chowdhary A. In vitro antifungal susceptibility profile and correlation of mycelial and yeast form of molecularly characterized Histoplasma capsulatum from India. Antimicrob Agents and Chemother, 2014; 58:5613-6. doi: 10.1128/AAC.02973-14. Epub 2014 Jun 30. Impact factor: 4.84

 

58.  Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, Meis JF. Multi-azole resistant A. fumigatus in the environment of Tanzania. Journal Antimicrobial Chemother 2014; 69:2979-83. doi: 10.1093/jac/dku259. Impact factor: 4.84

 

59.  Najafzadeh MJ, Sutton DA, SaradeghiKeisari M, Zarrinfar H, Sybren de Hoog G, Chowdhary A ,Meis JF In vitro activity of 8 antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans. Antimicrob Agents and Chemother, 2014; 58:5629-31. doi: 10.1128/AAC.03095-14. Impact factor: 4.84

 

60.  Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, Meis JF. Molecular characterization and in vitro antifungal susceptibilities of 80 clinical isolates of mucormycetes in Delhi, India, Mycoses, 2014; 57 Suppl 3:97-107. doi: 10.1111/myc.12234. Epub 2014 Sep 23 Impact factor: 1.2

 

61.  Chowdhary A, Kathuria S, Kshitij A, Meis JF. Recognizing Filamentous Basidiomycetes as agents of Human Disease: a Review. Medical Mycology 2014;52:782-97. doi: 10.1093/mmy/myu047. Epub 2014 Sep 8. Impact factor: 1.9.

 

62.  Chowdhary A, Kathuria S, Agarwal K, Sachdeva N, Singh PK, Jain S, Meis JF. Voriconazole-resistant Penicillium oxalicum: An emerging pathogen in immunocompromised hosts. Open Forum Infectious Diseases, 2014; 1:1-7 doi:10.1093/ofid/ofu029.

 

63.  Kumar A, Babu R, Bijulal S, Abraham M, Sasidharan P, Kathuria S, Sharma C, Meis JF, Chowdhary A. Invasive Mycosis due to Species of Blastobotrys in Immunocompromised Patients with Reduced Susceptibility to Antifungals. J Clin Microbiol. 2014; 52:4094-9. doi: 10.1128/JCM.01977-14. Epub 2014 Aug 27.

 

64.  Chowdhary A, Perfect J, de Hoog GS. Black moulds and melanised yeasts pathogenic to humans. Cold Spring Harb Perspect Med 2014 doi: 10.1101/cshperspect.

 

65. Khillan V, Rathore N, Kathuria S, Chowdhary A. A rare case of breakthrough fungal pericarditis due to fluconazole resistant Candida auris in a patient with chronic liver disease. J Med Microbiol. 2014. DOI 10.1099/jmmcr.0.003707. Impact factor: 2.2.

 

66.  Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Guinea J, Hagen F, Meis J, Thompson GR 3rd, Turnidge J. Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex by the CLSI Broth Microdilution Method (M27-A3 document): A Multicenter Study. Antimicrob Agents and Chemother 2015; 59:666-8. doi: 10.1128/AAC.04055-14. Epub 2014 Oct

 

67.  Kathuria S, Sharma C, Singh PK, Agarwal P, Agarwal K, Hagen F, Meis JF, Chowdhary A. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLOS One 2014.

 

 

National Journals:

 

68.  Chowdhary A, Ahmad S, Khan ZU, Doval DC & Randhawa HS.  Trichosporon asahii as an emerging etiologic agent of disseminated Trichosporonosis: a case report and an update. Indian J. Med. Microbiol. 2004; 22: 16-22. Impact factor: 0.9.

 

69.  Randhawa HS, Kowshik T, Sinha KP, Sandhu RS & Chowdhary A. Rapid isolation of Aspergillus fumigatus on peptone glucose fluconazole agar from aqueous suspensions and sputum seeded with Candida albicans. Current Science (India) 2005; 88: 1-6. Impact factor: 0.8.

 

70.  Capoor RM, Nair D, Deb M, Ramesh V, Khanna G, Rajini, Aggarwal P, Chand R, Chowdhary A, Mussa AY, Randhawa HS. Endemic occurrence of sporotrichosis in Uttaranchal, India-report of two autochthonous cases.  Indian J Dermatol. 2007; 50 (4 Suppl II). S-10-S13

 

71.  Randhawa HS, Chowdhary A. Medical Mycology in India (1957-2007): Contributions by the VPCI Mycoses Group. Indian J Chest Dis Allied Sci. 2008; 50: 19-32.

 

72.  Agarwal K, Chowdhary A, Gaur SN. A rare case of allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Indian J Allergy, Asthma Imunnol. 2012; 26: 20-24.

 

73.  Sharma B, Ghosh G, Kamble U, Chaudhary K, Chauhan A, Lamba BM, Chowdhary A, Gupta BB. Allergic broncho pulmonary aspergillosis complicated by nocardiosis. Case Rep Pulmonol. 2012; 2012:758630. doi: 10.1155/2012/758630.

 

74. Kapoor L, Chowdhary A, Malhotra VL, Bhatt V. Giardiasis -Clinical and diagnostic perspective. J. Commun Dis 2001; 33: 72-77.

 

75.  Chowdhary A, Malhotra VL, Deb M, Rai U: Screening for Chalmydial infections in women with pelvic inflammatory diseases. J. Commun Dis 1998; 30: 163-166.

 

76.  Revathi G, Chowdhary A. Amoxycillin / clavulinic acid resistance in clinical isolates of Escherichia coli. J. Basic Appl BioMed 1997; 5-8.